CytomX Therapeutics (CTMX) EBT (2014 - 2026)
CytomX Therapeutics (CTMX) posted EBT of -$18.2 million for Q1 2026, up 31.25% on a QoQ basis from -$26.5 million in Q4 2025, and down 177.11% year-over-year from $23.6 million in Q1 2025.
CytomX Therapeutics (CTMX) EBT (2014 - 2026) Analysis & Trends
CytomX Therapeutics' EBT history runs 13 years deep, the most recent figure standing at -$18.2 million for Q1 2026.
- Quarterly EBT fell 177.11% year-over-year to -$18.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$58.9 million (down 240.79% YoY) and the FY2025 annual result came in at -$17.1 million, down 153.38% from the prior year.
- EBT was -$18.2 million for Q1 2026 at CytomX Therapeutics, up from -$26.5 million in the prior quarter.
- Across five years, EBT topped out at $23.6 million in Q1 2025 and bottomed at -$32.0 million in Q1 2022.
- A 5-year average of -$5.8 million and a median of -$3.3 million in 2023 frame the typical range for EBT.
- Peak annual rise in EBT reached 893.6% in 2024, while the deepest fall reached 496.41% in 2024.
- CytomX Therapeutics' EBT stood at -$8.8 million in 2022, then jumped by 121.72% to $1.9 million in 2023, then surged by 893.6% to $18.9 million in 2024, then slumped by 239.7% to -$26.5 million in 2025, then jumped by 31.25% to -$18.2 million in 2026.
- Business Quant data shows CTMX's EBT at -$18.2 million in Q1 2026, -$26.5 million in Q4 2025, and -$14.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | CytomX Therapeutics | 574.36 Mn | 227.66 Mn | - | -18.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.19 Mn |
| Dec 31, 2025 | -26.46 Mn |
| Sep 30, 2025 | -14.17 Mn |
| Jun 30, 2025 | -91,000.00 |
| Mar 31, 2025 | 23.59 Mn |
| Dec 31, 2024 | 18.94 Mn |
| Sep 30, 2024 | 5.80 Mn |
| Jun 30, 2024 | -6.48 Mn |
| Mar 31, 2024 | 13.84 Mn |
| Dec 31, 2023 | 1.91 Mn |
| Sep 30, 2023 | 5.82 Mn |
| Jun 30, 2023 | -1.09 Mn |
| Mar 31, 2023 | -3.31 Mn |
| Dec 31, 2022 | -8.78 Mn |
| Sep 30, 2022 | -29.06 Mn |
| Jun 30, 2022 | -29.50 Mn |
| Mar 31, 2022 | -31.98 Mn |
| Dec 31, 2021 | -34.82 Mn |
| Sep 30, 2021 | -30.98 Mn |
| Jun 30, 2021 | -26.74 Mn |